{"altmetric_id":2925793,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"news":{"unique_users_count":1,"unique_users":["bioportfolio"],"posts_count":1},"total":{"posts_count":1}},"citation":{"altmetric_jid":"4f6fa52f3cf058f610004274","doi":"10.1038\/nrrheum.2014.203","first_seen_on":"2014-11-26T09:03:50+00:00","issns":["1759-4790","1759-4804"],"journal":"Nature Reviews Rheumatology","last_mentioned_on":1416991081,"links":["http:\/\/feeds.nature.com\/~r\/nrrheum\/rss\/aop\/~3\/2jVcbOUd5cE\/nrrheum.2014.203"],"pmid":"25422001","pubdate":"2014-11-25T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Connective tissue diseases","scheme":"npg"},{"name":"Therapeutics","scheme":"npg"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["rheumatology"],"title":"Lupus nephritis: Multitarget induction therapy versus cyclophosphamide","type":"article"},"altmetric_score":{"score":7,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7},"context_for_score":{"all":{"total_number_of_other_articles":4553834,"mean":5.3241366058634,"rank":587611,"this_scored_higher_than_pct":86,"this_scored_higher_than":3938779,"rank_type":"exact","sample_size":4553834,"percentile":86},"similar_age_3m":{"total_number_of_other_articles":145274,"mean":8.1969411246413,"rank":24215,"this_scored_higher_than_pct":82,"this_scored_higher_than":119623,"rank_type":"exact","sample_size":145274,"percentile":82},"this_journal":{"total_number_of_other_articles":774,"mean":5.7633661060802,"rank":206,"this_scored_higher_than_pct":70,"this_scored_higher_than":542,"rank_type":"exact","sample_size":774,"percentile":70},"similar_age_this_journal_3m":{"total_number_of_other_articles":46,"mean":15.424444444444,"rank":34,"this_scored_higher_than_pct":13,"this_scored_higher_than":6,"rank_type":"exact","sample_size":46,"percentile":13}}},"demographics":[],"posts":{"news":[{"title":"Lupus nephritis Multitarget induction therapy versus cyclophosphamide","url":"http:\/\/www.bioportfolio.com\/news\/article\/2150496\/Lupus-nephritis-Multitarget-induction-therapy-versus-cyclophosphamide.html","license":"public","citation_ids":[2925793],"posted_on":"2014-11-26T08:38:01+00:00","summary":"","author":{"name":"Bioportfolio","url":"http:\/\/www.bioportfolio.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/821\/normal\/Screen_Shot_2015-12-11_at_16.36.54.png?1449851849"}}]}}